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Highlights Canine Muscular Sarcocystosis_ Sukura et al 
- Fatal muscular sarcocystosis in a dog  
- Sarcocystis caninum and Sarcocystis svanai have global distribution  
- co-infection with S. caninum and S. svanai caused fatal myopathy in a dog 




Typically, carnivores are the definitive and herbivores the intermediate hosts for protozoan 
Sarcocystis spp. In the definitive host, the parasite has sexual multiplication in the 
intestine. Asexual phases occur in the musculature of different intermediate hosts. 
Although intestinal sarcocystosis is common in dogs, muscular symptomatic sarcocystosis 











had acute onset of non-ambulatory tetraparesis. While neurological findings suggested a 
generalized neuromuscular disease with peripheral neuropathy concordant with the 
neurological deficits, the highly elevated muscle enzymes were more suggestive of a 
myopathy. Despite supportive therapy, the dog died three days after the onset of clinical 
signs. Necropsy revealed severe monophasic multifocal myodegeneration with severe 
pyogranulomatous inflammation. Histology revealed multiple sarcocysts in skeletal 
muscles and a smaller number in the heart. In light microscopy, both thin-walled and very 
thin-walled sarcocysts were found in skeletal muscles. Transmission electron microscopy 
confirmed the presence of two types of mature sarcocysts. Morphologically, cysts were 
indistinguishable from Sarcocystis caninum and Sarcocystis svanai, which were previously 
reported in a dog from USA. A region of the 18S rRNA gene sequence confirmed the 
presence of one species, S. arctica/caninum, without evidence for a dual infection. This is 
the first report of muscular sarcocystosis in a dog in Europe and, intriguingly, revealed 
morphologically similar species across the Atlantic. 
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1. Introduction 
Although the dog is the major definitive host for Sarcocystis (with several species found in 
feces) (Dubey et al., 2016), muscular sarcocystosis in dogs is rarely reported (Sykes et al., 
2011, Chapman et al., 2005, Dubey et al., 2015, Dubey et al., 2016) and is often an 
incidental finding. Dubey et al. (2016) reviewed eight reported cases of muscular 
sarcocystosis in dogs, five of which with related clinical signs. Here we report a fatal case 











was necrotizing myopathy with secondary pyogranulamatous myositis. Intriguingly, two 
morphologically distinct Sarcocystis species were revealed; these resembled Sarcocystis 
caninum and Sarcocystis svanai. DNA sequencing confirmed the presence of S. 
arctica/caninum, but failed to provide evidence for S. svanai.  A dual infection with these 
two species has been  previously reported in a dog in Canada (Dubey et al., 2015). 
Previous other reports of canine muscular sarcocystosis were from the USA, Canada, 
India, and Kenya (reviewed by Dubey et al., 2016). 
 
2. Material and methods 
 
Case history: A six-year-old male neutered Bichon Frise was presented to Helsinki 
University Veterinary Teaching Hospital (HUVTH) in July 2016 with a history of acute 
weakness in all four limbs. The owners noticed the first clinical signs in the previous 
evening; no abnormalities were observed before. Otherwise, the dog was healthy and had 
never traveled abroad. Despite supportive therapy, the dog died on the third day after 
onset of clinical signs and was sent to necropsy (Faculty of Veterinary Medicine, University 
of Helsinki). 
Routine necropsy was performed. Samples were taken from all parenchymal organs and 
from the skeletal muscles, peripheral nerves, spinal cord, and brain. Samples were fixed in 
neutral buffered 10% formalin. Tissues were routinely processed, sectioned at 5-µm 
thickness and stained with hematoxylin and eosin (HE) and later with Periodic acid-Schiff 












Skeletal muscle tissue fixed for LM was also used for transmission electron microscopy 
(TEM). Formalin-fixed skeletal muscle tissue was cut into 1 mm3 pieces and further fixed 
with 2% glutaraldehyde in 100 mM phosphate buffer overnight at +10°C. Samples were then 
post fixed with 1% buffered osmium tetroxide for 1 h. After dehydration, the specimens were 
epon-embedded into embedding resin (TAAB Ltd., UK). All steps after fixation were 
performed at room temperature. Semi-thin sections were cut and stained with Toluidine Blue 
for LM. Areas with identified cysts were selected for ultrathin sectioning. Sections were 
collected on pioloform-coated single-slot copper grids and post-stained with 1% aqueous 
uranyl acetate and lead citrate (Leica Ultrostain II). Sections were analyzed by a JEM 1400 
transmission electron microscope (Jeol Ltd, Japan) operated at 80 kV. Images were 
acquired with an Orius SC1000B bottom-mounted CCD camera (Gatan Inc., USA).  
 
For molecular identification, individual sarcocysts were not isolated. Rather, total genomic 
DNA was extracted from paraffin-embedded skeletal muscle tissue using a DNeasy® 
Blood and Tissue kit (QIAGEN, CA). PCR was performed using nested primers targeted to 
the partial small subunit 18S rRNA gene. The sequence variation in the target region 
among species of Sarcocystis allows species level identification. For the first (external) 
PCR reaction, published primers 18S9L and 18S1H (Li et al., 2002) were used, of which 
the first was slightly modified (by adding G at the position 9: 18S9Lmod-
GGATAACCGTGGTAATTCTATG) to correspond to sequence of Sarcocystis spp. For the 
second (nested) PCR reaction, new Sarcocystis specific primers 18Sf1-
CAAGTTTCTGACCTATCAGC and 18Sr1-CCTATCTTGTTATTCCATGC were designed. 
The reaction mixture (50 µl) contained 1 µl of template DNA solution, 20 pmol of each 
primer (forward and reverse), 0.2 mM of each dNTP, 1 U of DreamTaq™ DNA polymerase 











nested PCR amplification, 1 µl of the external PCR product was used as a template. The 
PCR reaction conditions were as follows: initial denaturation step at 94°C for 10 min, 
followed by 35 cycles of 94°C for 60 sec, 54°C for 60 sec and 72°C for 120 sec, and a final 
extension at 72°C for 10 min. The nested PCR product obtained was excised from the 
agarose gel, purified with QIAquick® Gel Extraction kit (QIAGEN), and sequenced at the 
Institute for Molecular Medicine Finland SeqLab using the same primers as for nested 
PCR. The sequences were visualized, aligned, and compared with the previously 
published sequences using Geneious version R8 (http://www.geneious.com). 
 
3. Results and discussion 
The dog was unable to walk upon admission to HUVTH. At physical examination, the dog 
exhibited strenuous breathing while excited. Neurological examination by board-certified 
veterinary neurologists revealed non-ambulatory tetraparesis and absent (hind limbs) and 
severely decreased postural reactions (front limbs). Spinal reflexes were severely 
decreased to absent in all four limbs. Menace response and palpebral reflex were 
bilaterally decreased. There was no pain in palpation of the head, spine, or limbs. On the 
basis of the neurological examination findings, a generalized neuromuscular or lower 
motor neuron disease was suspected. Complete blood cell count revealed no 
abnormalities. A biochemistry panel showed increased serum AST (459 U/l; range 17-54) 
and CK activity (5018 U/l; range 60-235). Additionally, triglycerides were high (1.93 mmol/l; 
range 0.1-0.5) but cholesterol was within the reference range. Thoracic radiographs 
revealed no abnormal findings. The dog was anesthetized for electrodiagnostic 
investigations. Electromyography showed no changes in insertional activity and no 
spontaneous activity. Motor nerve conduction velocities from peroneal and ulnar nerves 











temporal dispersion. Repetitive nerve stimulation showed no decrement. IgG and IgM 
Toxoplasma gondii and IgG Neospora caninum serology titres measured with indirect 
immunofluorescence (IDEXX Laboratories, Ludwigsburg, Germany) were negative. 
Furthermore, serology test for acetylcholine receptor (AChR) antibodies (Comparative 
Neuromuscular Laboratory, La Jolla, CA, USA) was negative. A suspected diagnosis of 
acute polyradiculoneuritis was made, although the highly elevated muscle enzymes were 
not typical for the disease. 
The dog was hospitalized and supportive care (paracetamol, ondansetron, 
metoclopramide and IV fluid therapy) was administered. An indwelling urinary catheter was 
also placed. The following day, the dog improved slightly and flexor reflexes were stronger 
than on the day of presentation. The dog was eating and drinking and the owners decided 
to take the dog home overnight. While at home, his status worsened and according to the 
owner the urine color changed to brown and the dog was panting. The owners took the 
dog back to HUVTH. Despite supportive care (IV fluids, oxygen cage, ondansetron, 
metoclopramide, paracetamol, methadone) in intensive care, the dog died due to 
respiratory distress.   
 
In a dog with acute lower motor neuron tetraparesis, the most important differential 
diagnoses include acute polyradiculoneuritis, botulism, acute fulminant myasthenia gravis, 
and tick paralysis. The presence of severely elevated CK and AST did not support any of 
these differential diagnoses. Additionally, there was no history of ingestion of suspicious 
material (such as raw meat or dead animals) that could be a source of botulinum toxin. 
Furthermore, tick paralysis has not been reported in Finland, and electrodiagnostic testing 
(RNS) or laboratory results (negative AChR antibodies) did not support a diagnosis of 











AST may indicate muscle or liver damage, or both. Previously reported clinical signs in 
canine muscular sarcocystosis include ataxia, stiff gait or inability to walk, generalized 
pain, anorexia, diarrhea, fever, and panting (Dubey et al., 2015). While our patient showed 
many similar signs, no pain reaction was detected in palpation of the muscles. 
 
At necropsy, macroscopic findings were almost insignificant. There was acute 
subcutaneous hemorrhage (5 x 2 cm) in the chest cranial to the right front leg. Acute 
hemorrhage was observed between muscle membranes under the left shoulder (7 x 3 cm) 
and under the left bicep femori muscle (5 x 1 cm). Submandibular lymph nodes were 
slightly enlarged and there were small hemorrhagic areas on cut surface. The liver was 
swollen, soft, and congested. There was one small (1 cm) nodular lesion in the left medial 
lobe of the liver. The right kidney (6 cm) was slightly larger than the left (5 cm). Some 
hyperemia (1 x 0.2 cm) was observed dorsally in the spinal cord at the area of cauda 
equine.  
 
The main histopathological finding was severe monophasic multifocal acute muscular 
necrosis with pyogranulomatous inflammation (Fig. 1). Skeletal muscle cells were 
multifocal rounded and hyper-eosinophilic; cross striation was absent in affected cells. The 
sarcoplasm was vacuolated and the sarcolemma was discontinuous. Neutrophils, 
lymphocytes, and macrophages were multifocal and surrounded and infiltrated necrotic 
muscle cells. Macrophages were actively phagocytozing necrotic sarcoplasm. Although 
numerous sarcocysts were detected in myofibers, fulminant inflammation was not focused 
in sarcocysts but in degenerate myocytes (Fig. 1 A). In immune-mediated myositis, 











was clearly secondary and focused on already necrotized myofibers, which excluded 
immune-mediated disorders but suggested myopathies. 
 
Cut surfaces of sarcocysts were round or oval, measuring 25 to 30 µm. Length was up to 
500 µm, depending on the section panel. Thin and very thin cyst walls were identified (Fig. 
1 B, C). Approximately 80% of the cysts showed thin appearance; a minority of the cysts 
had very thin cyst walls. Inside the cysts, numerous small (1-2 µm) and round basophilic 
structures with a surrounding clear halo were observed (Fig. 1 B, C). These structures had 
PAS-positive granules. One sarcocyst was also observed in the myocardium without any 
inflammatory reaction. Cysts were negative for Toxoplasma immunostaining. Endothelium 
of different organs were carefully investigated for intravascular schizonts; none were 
discovered.  
 
The histopathological pattern indicates that sarcocysts in the dog did not initiate a 
fulminant inflammatory reaction but may have been directly toxic to myocytes. Myositis 
was secondary reaction due to removal of debris from necrotized myocytes. The observed 
monophasic reaction may be related to the rapid onset of the episode; if the animal lived 
longer there could have been muscle fibers in different phases that also showed fibrosis 
and regeneration. It is not possible to differentiate between monophasic and early 
polyphasic reaction types.  
 
There was acute severe diffuse congestion with some acute hemorrhages surrounding 
veins in the liver. Hepatocytes were diffusely slightly vacuolated and some apoptotic 











Sarcocyst walls were slightly different at LM level and showed two distinct types in TEM 
evaluation. Sarcocyst wall structures have been used for specific diagnosis. Dubey et al 
(2016) reviewed at least 82 distinct types of cyst walls; these were grouped into Types 1 to 
42 with subtypes. Ultrastructurally, very thin cyst walls mimic type 1 (Fig 2 A-C) and the 
thin wall cysts mimic type 9 (Fig 2 D-F) (Dubey et al, 2016). Near the sarcocyst host cell, 
severe necrotizing and autolytic changes were observed (Fig 2 A). On the basis of ultra-
morphology, the type 9 and type 1 cell wall sarcocysts were very similar to Sarcocystis 
caninum and Sarcocystis svanai, respectively. These pathogens have been previously 
reported to cause a symptomatic disease in a dog in USA and Canada (Dubey et al, 
2015).  
 
A region of 18S rRNA gene, 461 bp in length, was successfully sequenced. Double peaks, 
which could support the presence of more than one species, were not detected in the 
sequencing chromatograms. The DNA sequence has been deposited in GenBank under 
the accession number MG851712. A comparison with the previously published sequences 
in GenBank showed 100% identity with S. caninum (GenBank accession no. KM362427) 
and S. arctica. (eg, KF601301). Dubey et al. (2015) noted that the 18S rRNA gene 
sequence is identical in S. caninum and S. arctica. These two species might be 
conspecific (S. caninum as a junior synonym of S. arctica). Sequence identity of the 
present specimen with S. svanai (eg. KM362428) was 99% (difference of 5 bp, including 4 
substitutions and 1 insertion). In the sections used for DNA extraction, the number of S. 
svanai-like organisms may have been insufficient for DNA amplification, and thus the 
unambiguous sequencing result does not exclude a dual infection with S. arctica/caninum 











S. svanai-type; the ratio may likely have influence also DNA amplification from the paraffin 
sections.  
 
A similar combination of parasites that causes similar disease in USA and Europe 
indicates that Sarcocystis are not accidentally in canine musculature but have adapted to 
the dog also as an intermediate host. Similar clinical signs in reports of all clinically 
affected dogs have shown that these parasites alone, or in a coinfection, are pathogenic to 
dogs. The total life cycle of these parasites with the definitive host is still unknown. 
 
Sarcocystis arctica, with similarities to S. caninum, has been detected in the muscles of 
arctic foxes (Vulpes lagopus) in Norway (Gjerde et Schulze, 2014) and Alaska (Cerqueira-
Cézar, 2017) and in wolves (Canis lupus) in Alaska (Calero-Berna, 2016). These 
observations demonstrate that canines globally can act as an intermediate host for the 
species. Sarcocystis svanai, which has morphological similarities to our type 1 sarcocysts, 
has been reported not only in a dog in USA (Dubey et al., 2015) but also in Pampas foxes 
(Lycalopex gymnocercus) in Argentina with high prevalence (Scioscia et al., 2017).  
 
Our results confirmed clinical canine sarcocystis myopathy with global reach and identified 
two ultrastructurally similar Sarcocystis species that use the dog as an intermediate host. 
Clinically, sarcocystosis should be considered as a differential diagnosis in dogs with acute 
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Fig. 1. Skeletal muscle with thin (A, B) and very thin walled (C) sarcocysts. A,  Note that 
sarcocysts (SC) do not evoke fulminate inflammation. Rather, secondary inflammation is 
seen in necrotized tissue. Degenerate muscle cells (asterisk), hemorrhage, and 
macrophages clearing necrotized material (arrow). Sarcocysts had thin wall (B) but some 
had very thin appearance (C). B, C, Inside the sarcocysts were multiple 











Fig. 2 A-C. A, Type 1 sarcocyst wall (arrow). The host cell near the sarcocyst showed 
pronounced necrotizing/autolytic changes (asterisk). B, Sarcocyst wall type 1 without 
villous projections, inside maturating bradyzoites with typical sturctures like amylopectin 
granules (apg), dense granules (dg), nucleus (n), and micronemes (Mn). Slight septa-like 
structures divide the sarcocyst in lobules (B). Details of sarcocyst wall that are less than 
0.5 µm thick, the parasitophorous membrane (pvm) has an electron-dense inner layer, 
which is absent in invaginate areas (arrow, C). D-F Type 9-like cyst type showed villar 
pleomorphic protrusions (arrow, D). The cyst wall was almost four times thicker, reaching 
1.5-2 µm width. (E, F). Detail of the cyst wall, invaginations in deeper section of villous 
bottom in which the electron-dense layer of pvm was absent (arrow, F), host myofiber (mf).  
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